BIOMAT Database Logo BIOMAT Database Logo

[Niflumic acid in the treatment of rheumatic disease]. 1970

E Lejeune, and P Queneau, and M Falconnet, and R Woerhle

UI MeSH Term Description Entries
D007592 Joint Diseases Diseases involving the JOINTS. Arthropathies,Arthropathy,Joint Disease
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009539 Nicotinic Acids 2-, 3-, or 4-Pyridinecarboxylic acids. Pyridine derivatives substituted with a carboxy group at the 2-, 3-, or 4-position. The 3-carboxy derivative (NIACIN) is active as a vitamin. Acids, Nicotinic
D010003 Osteoarthritis A progressive, degenerative joint disease, the most common form of arthritis, especially in older persons. The disease is thought to result not from the aging process but from biochemical changes and biomechanical stresses affecting articular cartilage. In the foreign literature it is often called osteoarthrosis deformans. Arthritis, Degenerative,Osteoarthrosis,Osteoarthrosis Deformans,Arthroses,Arthrosis,Arthritides, Degenerative,Degenerative Arthritides,Degenerative Arthritis,Osteoarthritides,Osteoarthroses
D011111 Polymyalgia Rheumatica A syndrome in the elderly characterized by proximal joint and muscle pain, high erythrocyte sedimentation rate, and a self-limiting course. Pain is usually accompanied by evidence of an inflammatory reaction. Women are affected twice as commonly as men and Caucasians more frequently than other groups. The condition is frequently associated with GIANT CELL ARTERITIS and some theories pose the possibility that the two diseases arise from a single etiology or even that they are the same entity. Forestier-Certonciny Syndrome,Pseudopolyarthritis, Rhizomelic,Rheumatism, Peri-Extra-Articular,Forestier Certonciny Syndrome,Peri-Extra-Articular Rheumatism,Pseudopolyarthritides, Rhizomelic,Rheumatism, Peri Extra Articular,Rhizomelic Pseudopolyarthritides,Rhizomelic Pseudopolyarthritis,Syndrome, Forestier-Certonciny
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

E Lejeune, and P Queneau, and M Falconnet, and R Woerhle
[Liver tolerance of niflumic acid during treatment of degenerative rheumatic disease].
December 1972, Therapie der Gegenwart,
E Lejeune, and P Queneau, and M Falconnet, and R Woerhle
[Niflumic acid combined with gastroprotective agents in rheumatic pathology].
January 1974, Reumatismo,
E Lejeune, and P Queneau, and M Falconnet, and R Woerhle
[Osteofluorosis after prolonged niflumic acid treatment].
May 1980, La Nouvelle presse medicale,
E Lejeune, and P Queneau, and M Falconnet, and R Woerhle
[Niflumic acid].
January 1975, Reumatologia,
E Lejeune, and P Queneau, and M Falconnet, and R Woerhle
[Treatment of rheumatoid arthritis with niflumic acid].
January 1972, Revista medica de Chile,
E Lejeune, and P Queneau, and M Falconnet, and R Woerhle
[Niflumic acid in ophthalmology].
September 1970, Lyon medical,
E Lejeune, and P Queneau, and M Falconnet, and R Woerhle
[Niflumic acid in rheumatology].
January 1968, La Revue lyonnaise de medecine,
E Lejeune, and P Queneau, and M Falconnet, and R Woerhle
Niflumic acid in osteoarthrosis. A comparative study of niflumic acid and indomethacin in osteoarthrosis of the knee.
January 1973, Scandinavian journal of rheumatology. Supplement,
E Lejeune, and P Queneau, and M Falconnet, and R Woerhle
[Metabolism of the niflumic acid in rabbits].
November 1968, Annales pharmaceutiques francaises,
E Lejeune, and P Queneau, and M Falconnet, and R Woerhle
A clinical investigation of niflumic acid in the treatment of rheumatoid arthritis.
January 1973, Scandinavian journal of rheumatology. Supplement,
Copied contents to your clipboard!